TH MEDICAL-B (02697.HK): Signs strategic cooperation framework agreement with General Technology Liaoning Pharmaceutical

NewTimeSpace News: On 25 August 2026, Guangdong True Health Medical Technology Development Co., Ltd. (stock code: 02697) announced that the Company signed a strategic cooperation framework agreement with General Technology Liaoning Pharmaceutical Co., Ltd. (General Technology Liaoning Pharmaceutical) in Shenyang on 22 August 2026. The two parties will cooperate based in the three northeastern provinces, focusing on the construction of tumor minimally invasive diagnosis and treatment systems, compliant operation of equipment and enhancement of specialty capabilities, adopting models such as specialty co-construction, equipment technology services and operating leases to promote the standardized implementation of tumor minimally invasive interventional technologies; the project will strictly comply with relevant regulations, with filings to the health commission and medical insurance authorities completed before implementation.

The announcement stated that General Technology Liaoning Pharmaceutical is the only provincial-level platform company established in Liaoning Province by China Meheco Co., Ltd., which is under China General Technology (Group) Holding Co., Ltd., a key state-owned enterprise directly managed by the central government. The cooperation will accelerate the scaled implementation of the Company's self-developed tumor minimally invasive surgical robots and specialty solutions in the northeastern region, creating a replicable tumor specialty model and empowering regional healthcare upgrades.

The board believes that the cooperation achieves complementary advantages between the two parties, which is conducive to enhancing the Company's market influence and is in the interests of the Company and its shareholders as a whole.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.